Raj Mehra - Net Worth and Insider Trading

Raj Mehra Net Worth

The estimated net worth of Raj Mehra is at least $27,772 dollars as of 2024-05-30. Raj Mehra is the See Remarks of Seelos Therapeutics Inc and owns about 23,143 shares of Seelos Therapeutics Inc (SEEL) stock worth over $27,772. Details can be seen in Raj Mehra's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Raj Mehra has not made any transactions after 2023-12-01 and currently still holds the listed stock(s).

Transaction Summary of Raj Mehra

To

Raj Mehra Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Raj Mehra owns 3 companies in total, including Seelos Therapeutics Inc (SEEL) , Larkspur Health Acquisition Corp (LSPR) , and ZyVersa Therapeutics Inc (ZVSA) .

Click here to see the complete history of Raj Mehra’s form 4 insider trades.

Insider Ownership Summary of Raj Mehra

Ticker Comapny Transaction Date Type of Owner
SEEL Seelos Therapeutics Inc 2023-12-01 director & See Remarks
LSPR Larkspur Health Acquisition Corp 2021-12-20 director
ZVSA ZyVersa Therapeutics Inc 2021-12-20 director

Raj Mehra Latest Holdings Summary

Raj Mehra currently owns a total of 1 stock. Raj Mehra owns 23,143 shares of Seelos Therapeutics Inc (SEEL) as of December 1, 2023, with a value of $27,772.

Latest Holdings of Raj Mehra

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SEEL Seelos Therapeutics Inc 2023-12-01 23,143 1.20 27,772

Holding Weightings of Raj Mehra


Raj Mehra Form 4 Trading Tracker

According to the SEC Form 4 filings, Raj Mehra has made a total of 3 transactions in Seelos Therapeutics Inc (SEEL) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Seelos Therapeutics Inc is the acquisition of 9,470 shares on December 1, 2023, which cost Raj Mehra around $99,999.

Insider Trading History of Raj Mehra

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Raj Mehra Trading Performance

GuruFocus tracks the stock performance after each of Raj Mehra's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Raj Mehra is -15.08%. GuruFocus also compares Raj Mehra's trading performance to market benchmark return within the same time period. The performance of stocks bought by Raj Mehra within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Raj Mehra's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Raj Mehra

Average Return

Average return per transaction

Outperforming Transactions

1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -18.64
Relative Return to S&P 500(%) -10.43

Raj Mehra Ownership Network

Ownership Network List of Raj Mehra

No Data

Ownership Network Relation of Raj Mehra


Raj Mehra Owned Company Details

What does Seelos Therapeutics Inc do?

Who are the key executives at Seelos Therapeutics Inc?

Raj Mehra is the director & See Remarks of Seelos Therapeutics Inc. Other key executives at Seelos Therapeutics Inc include Chief Financial Officer Michael Joseph Golembiewski , director & CEO & Secretary Richard W Pascoe , and SVP & Chief Business Officer Neil Morton .

Seelos Therapeutics Inc (SEEL) Insider Trades Summary

Over the past 18 months, Raj Mehra made 1 insider transaction in Seelos Therapeutics Inc (SEEL) with a net purchase of 75,757. Other recent insider transactions involving Seelos Therapeutics Inc (SEEL) include a net purchase of 83,000 shares made by Michael Joseph Golembiewski ,

In summary, during the past 3 months, insiders sold 0 shares of Seelos Therapeutics Inc (SEEL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Seelos Therapeutics Inc (SEEL) were sold and 19,845 shares were bought by its insiders, resulting in a net purchase of 19,845 shares.

Seelos Therapeutics Inc (SEEL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Seelos Therapeutics Inc Insider Transactions

No Available Data

Raj Mehra Mailing Address

Above is the net worth, insider trading, and ownership report for Raj Mehra. You might contact Raj Mehra via mailing address: C/o Seelos Therapeutics, Inc., 300 Park Avenue, 12th Floor, New York Ny 10022.

Discussions on Raj Mehra

No discussions yet.